Page 7 of 10
The Journal of Organic Chemistry
6-Bromo-2-phenyl-1H-benzo[d]imidazole (4ca):22 GP
acetate in hexanes yielded (4bl) (51 mg, 52%) as a white
solid (mp 188- 192°C). 1H NMR (400 MHz, DMSO-d6) δ
12.42 ( br s, 1H), 7.92 (d, J = 1.3 Hz, 1H), 7.44 (d, J = 8.2 Hz,
1H), 7.34 (s, 1H), 7.16 (d, J = 3.3 Hz, 1H), 7.02 (dd, J = 8.3, 1.0
Hz, 1H), 6.71 (dd, J = 3.3, 1.8 Hz, 1H), 2.41 (s, 3H). 13C{1H}
NMR (101 MHz, DMSO-d6) δ 145.7, 144.4, 143.3, 138.4,
131.5, 131.4, 123.7, 115.0, 114.0, 112.3, 110.2, 21.3.
1
2
3
4
5
6
7
8
was followed using cobalt catalyst (3) (6.5 mg, 5.0 mol%),
4-bromo-2-nitroaniline (1c) (108 mg, 0.5 mmol), and phe-
nylmethanol (2a) (108 mg, 1.0 mmol). After 24 h, purifica-
tion by column chromatography using 10% ethyl acetate in
1
hexanes yielded (4ca) (74 mg, 54%) as a liquid. H NMR
(400 MHz, CDCl3 + DMSO-d6) δ 8.11 (dd, J = 4.2, 2.6 Hz, 2H),
7.68 (s, 1H), 7.46 – 7.36 (m, 4H), 7.31 – 7.18 (m, 1H). 13C{1H}
NMR (101 MHz, CDCl3 + DMSO-d6) δ 153.2, 140.4, 138.5,
130.3, 129.7, 129.0, 127.0, 125.7, 117.9, 116.5, 115.5.
6-Chloro-2-(naphthalen-1-yl)-1H-benzo[d]imidazole
(4dk):29 GP was followed using cobalt catalyst (3) (6.5 mg,
5.0 mol%), 4-chloro-2-nitroaniline (1d) (86 mg, 0.5 mmol),
and naphthalen-1-ylmethanol (2k) (158 mg, 1.0 mmol) Af-
ter 24 h, purification by column chromatography using 20%
ethyl acetate in hexanes yielded (4dk) (99 mg, 71%) as a
9
6-Chloro-2-phenyl-1H-benzo[d]imidazole (4da):26 GP
was followed using cobalt catalyst (3) (6.5 mg, 5.0 mol%),
4-chloro-2-nitroaniline (1d) (86 mg, 0.5 mmol), and phe-
nylmethanol (2a) (108 mg, 1.0 mmol). After 24 h, purifica-
tion by as a solid (mp 212-214 °C). column chromatography
using 10% ethyl acetate in hexanes yielded (4da) (60 mg,
52%).1H NMR (400 MHz, CDCl3 + DMSO-d6) δ 8.10 (dd, J =
6.5, 2.5 Hz, 2H), 7.53 (d, J = 1.3 Hz, 1H), 7.47 (d, J = 8.6 Hz,
1H), 7.42 – 7.36 (m, 3H), 7.13 (dd, J = 8.5, 1.6 Hz, 1H).13C{1H}
NMR (101 MHz, CDCl3 + DMSO-d6) δ 153.2, 130.2, 129.8,
129.2, 128.9, 128.7, 127.9, 126.9, 123.0, 116.1, 114.8.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
1
pale yellow liquid. H NMR (400 MHz, CDCl3 + DMSO-d6) δ
8.51 (dd, J = 9.8, 6.6 Hz, 1H), 7.79 – 7.67 (m, 2H), 7.62 (t, J =
7.2 Hz, 1H), 7.44 – 7.23 (m, 5H), 7.02 (dt, J = 8.8, 4.2 Hz, 1H).
13C{1H} NMR (101 MHz, CDCl3 + DMSO-d6) δ 152.8, 139.7,
137.7, 133.4, 130.8, 130.1, 128.0, 127.9, 127.6, 127.3, 126.8,
126.0, 125.7, 124.6, 122.4, 115.8, 114.7.
2-(3-Fluorophenyl)-5,6-dimethyl-1H-benzo[d]imidaz-
ole (4fg): GP was followed using cobalt catalyst (3) (6.5 mg,
5.0 mol%), 4,5-dimethyl-2-nitroaniline (1f) (83 mg, 0.5
mmol), and (3-fluorophenyl)methanol (2g) (126 mg, 1.0
mmol). After 24 h, purification by column chromatography
using 12% ethyl acetate in hexanes yielded (4fg) (54 mg,
45%). 1H NMR (400 MHz, DMSO-d6) δ 12.70 ( br s, 1H), 7.94
(d, J = 7.8 Hz, 1H), 7.87 (d, J = 10.2 Hz, 1H), 7.53 (dd, J = 14.1,
8.0 Hz, 1H), 7.39 (s, 1H), 7.25 (td, J = 8.6, 2.4 Hz, 2H), 2.28 (s,
6H). 13C{1H} NMR (101 MHz, DMSO-d6) δ 163.0 (d, J = 243.3
Hz), 149.6, 134.0, 133.3 (d, J = 8.4 Hz), 131.6 (d, J = 8.5 Hz),
122.8 (d, J = 2.3 Hz), 119.5, 116.7 (d, J = 21.2 Hz), 113.2 (d, J
= 23.6 Hz), 112, 20.5. 19F NMR (376 MHz, DMSO-d6) δ -112.4
(td, J = 9.4, 6.6 Hz). HRMS (ESI) m/z calculated for
C15H13FN2H [M+H]+ 241.1136, found 241.1139.
6-Methoxy-2-phenyl-1H-benzo[d]imidazole (4ea):22 GP
was followed using cobalt catalyst (3) (6.5 mg, 5.0 mol%),
4-methoxy-2-nitroaniline (1e) (84 mg, 0.5 mmol), and phe-
nylmethanol (2a) (108 mg, 1.0 mmol). After 24 h, purifica-
tion by column chromatography using 20% ethyl acetate in
hexanes yielded (4ea) (44 mg, 39%) as a white solid. (mp
146-147°C). 1H NMR (400 MHz, CDCl3) δ 8.07 (dd, J = 6.7, 3.0
Hz, 2H), 7.46 (d, J = 8.7 Hz, 1H), 7.38 – 7.34 (m, 3H), 6.99 (d,
J = 2.3 Hz, 1H), 6.85 (dd, J = 8.9, 2.4 Hz, 1H), 3.73 (s, 3H).
13C{1H} NMR (101 MHz, CDCl3) δ 156.9, 151.8, 139.1, 134.1,
130.1, 129.8, 129.2, 126.7, 116.2, 112.8, 97.5, 55.9.
5,6-Dimethyl-2-phenyl-1H-benzo[d]imidazole (4fa):22
GP was followed using cobalt catalyst (3) (6.5 mg, 5.0
mol%), 4,5-dimethyl-2-nitroaniline (1f) (83 mg, 0.5 mmol),
and phenylmethanol (2a) (108 mg, 1.0 mmol). After 24 h,
purification by column chromatography using 20% ethyl
acetate in hexanes yielded (4fa) (67 mg, 60%) as a white
2-(4-Fluorophenyl)-6-methyl-1H-benzo[d]imidazole
(4bn):30 GP was followed using cobalt catalyst (3) (6.5 mg,
5.0 mol%), 4-methyl-2-nitroaniline (1b) (76 mg, 0.5 mmol),
and (4-fluorophenyl)methanol (2n) (126 mg, 1.0 mmol)Af-
ter 24 h, purification by column chromatography using 20%
ethyl acetate in hexanes yielded (4bn) (52 mg, 46%) as a
1
solid. (mp 249-252°C). H NMR (400 MHz, CDCl3 + DMSO-
d6) δ 8.07 (d, J = 6.9 Hz, 2H), 7.42 – 7.26 (m, 5H), 2.28 (s, 6H).
13C{1H} NMR (101 MHz, CDCl3 + DMSO-d6) δ 151.1, 145.9,
138.3, 131.3, 130.5, 129.4, 128.7, 126.6, 20.4.
1
white solid (mp 180-182 °C). H NMR (400 MHz, CDCl3 +
DMSO-d6) δ 8.08 (dd, J = 8.3, 5.5 Hz, 2H), 7.44 (d, J = 8.2 Hz,
1H), 7.31 (s, 1H), 7.13 – 6.84 (m, 3H), 2.39 (s, 3H). 13C{1H}
NMR (101 MHz, CDCl3 + DMSO- d6) δ 163.6 (d, J = 249.8 Hz),
151.0, 132.4, 128.6 (d, J = 8.4 Hz), 126.7, 126.6, 124.1, 115.8
(d, J = 21.8 Hz), 115.1, 114.4, 99.9, 21.7. 19F NMR (376 MHz,
CDCl3) δ -110.8 (m).
6-Chloro-2-(3-methoxyphenyl)-1H-benzo[d]imidazole
(4de):27 GP was followed using cobalt catalyst (3) (6.5 mg,
5.0 mol%), 4-chloro-2-nitroaniline (1d) (86 mg, 0.5 mmol),
and (4-methoxyphenyl)methanol (2e) (138 mg, 1.0 mmol).
After 24 h, purification by column chromatography using
20% ethyl acetate in hexanes yielded (4de) (76 mg, 59%)
as a liquid. 1H NMR (400 MHz, CDCl3) δ 7.64 – 7.61 (m, 1H),
7.59 (d, J = 7.7 Hz, 1H), 7.53 (d, J = 1.9 Hz, 1H), 7.48 (d, J =
8.6 Hz, 1H), 7.30 (dd, J = 10.1, 5.8 Hz, 1H), 7.19 (dd, J = 8.6,
1.8 Hz, 1H), 6.96 (dd, J = 8.3, 2.2 Hz, 1H), 3.68 (s, 3H).13C{1H}
NMR (101 MHz, CDCl3) δ 160.3, 153.1, 139.6, 137.9, 130.6,
130.4, 128.8, 123.8, 119.0, 117.2, 116.2, 115.0, 111.7, 55.4.
2-(2,4-Dichlorophenyl)-6-methyl-1H-benzo[d]imidaz-
ole (4bo):31 GP was followed using cobalt catalyst (3) (6.5
mg, 5.0 mol%), 4-methyl-2-nitroaniline (1b) (76 mg, 0.5
mmol), and (2,4-dichlorophenyl)methanol (2o) (177 mg,
1.0 mmol). After 24 h, purification by column chromatog-
raphy using 12% ethyl acetate in hexanes yielded (4bo) (80
mg, 58%) as a white solid (mp 103-105 °C). 1H NMR (400
MHz, CDCl3) δ 10.01 ( br s, 1H), 7.47 (d, J = 8.3 Hz, 1H), 7.38
(s, 1H), 7.35 (s, 1H), 7.14 (d, J = 3.5 Hz, 1H), 7.03 (d, J = 8.6
Hz, 1H), 2.40 (s, 3H). 13C{1H} NMR (101 MHz, CDCl3) δ 145.3,
143.9, 138.1, 137.0, 133.1, 130.4, 124.7, 122.7, 120.7, 115.1,
114.6, 112.4, 111.0, 21.8.
2-(Furan-2-yl)-6-methyl-1H-benzo[d]imidazole (4bl):28
GP was followed using cobalt catalyst (3) (6.5 mg, 5.0
mol%), 4-methyl-2-nitroaniline (1b) (76 mg, 0.5 mmol),
and furan-2-ylmethanol (2l) (98 mg, 1.0 mmol). After 24 h,
purification by column chromatography using 12% ethyl
ACS Paragon Plus Environment